Danielle Scheflen currently serves as the Director - Immunology Brand Lead at Sandoz, responsible for the marketing strategy and commercial success of a ustekinumab biosimilar launch in the U.S. Previously, Danielle held the position of Associate Director Marketing - Immunology at Novartis, where responsibilities included developing strategic account plans for copay vendors. Prior experience at Sandoz involved the role of Associate Director, and at UBC - An Express Scripts Company, Danielle was a Project Manager overseeing cross-functional teams for commercial and REMS programs. Danielle began a career at Covance as an Associate Project Manager and holds a Bachelor of Science degree in Psychology from Bloomsburg University of Pennsylvania.